ZYME Q1 2021 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$644,000-92.2% YoY

Gross Profit

-$44M-6776.2% margin

Operating Income

-$45M-6977.5% margin

Net Income

-$45M-6923.9% margin

EPS (Diluted)

$-0.87

QoQ Revenue Growth

-95.9%

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$41M

Stock-Based Comp.

-$7M

Balance Sheet

Total Assets

$490M

Total Liabilities

$113M

Stockholders' Equity

$377M

Cash & Equivalents

$280M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$644,000	$8M	-92.2%
Gross Profit	-$44M	-$29M	-52.2%
Operating Income	-$45M	-$36M	-25.2%
Net Income	-$45M	-$31M	-43.2%

Revenue Segments

Other Product

$644,000100%